Sewoon Medical Q1 Consolidated Sales 15.4B Won, OP 3.4B Won, EPS 81 Won (+29% YoY)

Consolidated Q1 revenue 15.4B won (+5.7% YoY), operating profit 3.4B won, net profit 3.6B won.
Standalone Q1 revenue 15.6B won, operating profit 3.0B won, net profit 3.4B won.
EPS 81 won (+28.6% YoY from 63 won), basic EPS consolidated 81 won.
Dividend: 70 won per share for FY2025 (vs 60 won prior), total 2.95B won paid in April 2026.
Financial structure: debt ratio 7.1%, cash equivalents 99.8B won, debt-free.
Subsidiaries: Standard Cytech (63.82%) net profit 0.44B won; Sewoon Medical LLC (Vietnam) net loss 0.08B won.
R&D expense 0.36B won (2.34% of revenue), 11 researchers.
No significant litigation or contingent liabilities.